71/100 B+ · Critical risk
1 serious risk flag found TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.
  • 🔴 Insolvency / collective proceedings on file (2)

PHARNEXT

Active 5308 7219 Active for 19 years

5308 · RC 498098425 · Active since 2007

B+

Overview

PHARNEXT is a 5308 registered , France, since 2007. The company operates in the 7219 sector. With reported revenue of 7K EUR in 2022. Its TraceComp score of 71 (B+) indicates moderate risk with some areas to watch. With 19 years of operations, the company has an established track record in its market.

Company Information

Registration Number
498098425
Legal Form
5308
Registered
2007-04-16

Financial Profile

Latest filed accounts: FY 2022 · most recent available in public filings

Revenue (2022) 7,225 EUR
Net Income -28,442,460 EUR
Total Assets 6,591,149 EUR
Altman Z -18.22 distress

Multi-year financials & ratios

5 years of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

7 officers/directors on file — names, roles, appointment & resignation dates.

NameRoleStatus
JULIEN Herenberg role 72 Current
+ 6 more in the full report

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Insolvency & Collective Proceedings

2 insolvency / collective-proceedings notices on file — most recent published 2026-03-06. A material adverse finding for counterparty and credit risk.

Insolvency notice types, titles, publication dates and official Gazette sources.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Research Output

Active research organization. 58 publications · 10,443 citations · h-index 64 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Neuroscience (33%) · Medicine (33%) · Biochemistry, Genetics and Molecular Biology (21%).

See full research profile — top researchers & publications →

Source: OpenAlex (CC0). Objective publication & citation counts.

Patent Portfolio

Active patent holder. 54 patents · 54 active · 54 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • Revenue down 88% year-on-year
  • Net loss reported in FY 2022
  • Altman Z-Score in the distress zone — elevated insolvency risk on the model

Data Sources & Freshness

Data sourced from: bulk register.